Oxford Biodynamics

OBD · AIM · Health Care · mcap £16m · 0.1p

Beta Briefing, track record and bull & bear case are not ready for Oxford Biodynamics yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 38 companies are already wired into a briefing: browse them.

Vulpes Investment Management Pte Ltd 25 Nov · 1 notice

12.9% → 14.4%

share price at the notices 0.3p · now 0.1p 25 Nov 2025

Octopus Investments Limited 28 Aug · 1 notice

below 3% → 11.9%

share price at the notices 0.1p · now 0.1p 28 Aug 2026

Pentwater Capital Management LP 12 Nov – 1 Sep · 2 notices

below 3% → 8.9%

share price at the notices 0.1–0.3p · now 0.1p 12 Nov 2025 1 Sep 2026

Unicorn Asset Management Limited 11 Nov · 2 notices

7.4% → 6.5%

share price at the notices 0.3p · now 0.1p 11 Nov 2025 11 Nov 2025

Spreadex LTD 28 Aug · 1 notice

1.8% → 5.3%

share price at the notices 0.1p · now 0.1p 28 Aug 2026

Sankofa Strategic Equity Fund Ltd 27 Jan – 17 Sep · 2 notices

4.9% → 4.9%

share price at the notices 0.1–0.3p · now 0.1p 27 Jan 2026 17 Sep 2026

Trafalgar Trading Fund Inc. 30 Mar · 1 notice

0.6% → 3.0%

share price at the notices 0.2p · now 0.1p 30 Mar 2026

6 Oceans Capital Partners Pty Limited 17 Jul – 1 Sep · 2 notices

below 3% → 1.9%

share price at the notices 0.1p · now 0.1p 17 Jul 2026 1 Sep 2026

Trafalgar Capital Management (HK) Limited 11 Nov – 17 Jul · 3 notices

2.5% → 0.0%

share price at the notices 0.1–0.3p · now 0.1p 11 Nov 2025 20 Mar 2026 17 Jul 2026

Directors

No open-market share purchases by directors in 12 months.

other 7 Nov 2025

award Oxford BioDynamics Plc has granted 170,000,000 share options to employees and advisers, including directors, at an exercise price of 0.61 pence per share, a 100% premium to the previous day's closing price. Of these, 119 10 Nov 2025

other Oxford BioDynamics Plc announced that Stephen Diggle has stepped down as a Director, having served as Non-Executive Director since October 2016. Vulpes Investment Management, controlled by Diggle, remains the company's l 26 Jan 2026

award Oxford BioDynamics Plc has granted 1,008,068,322 share options to Chief Executive Officer Richard Compton under its 2016 Employee Share Option Plan. These options are split into three tranches of 336,022,774 each, with e 18 Sep 2026

Company filings. Not investment advice.